Has Leon Kircik, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,983,187 in general payments to Leon Kircik, MD across 4,103 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Leon Kircik, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Leon Kircik, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Leon Kircik, MD

Dermatology · Lousiville, KYNPI 1760576599

Payments from drug & device makers

$9,983,187in general payments, 2019–2025

Across 4,103 payments — averaging $2433.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Almirall LLC$1.1M
Incyte Corporation$882K
E.r. Squibb & Sons, L.L.C.$802K
Eli Lilly$657K
Sun Pharmaceutical Industries Inc.$631K
Sanofi US Services Inc.$620K
plus $5.3M from 47 others

$1,329,159in research payments, 2019–2025

Across 52 payments — averaging $25,561 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

LEO Pharma Inc.$702K
Bausch Health US, LLC$270K
Almirall LLC$122K
Sanofi US Services Inc.$111K
Sun Pharmaceutical Industries Inc.$75K
Sanofi$15K
plus $34K from 3 others

What the payments were for

Consulting fees$1,648,77537%
Speaking & faculty fees$2,178,33549%
Grants$156,1703%
Travel & lodging$418,1399%
Food & beverage$59,5211%
Education$16,9410%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Almirall LLC	116	$1,074,425
Incyte Corporation	316	$882,291
E.r. Squibb & Sons, L.L.C.	239	$801,723
Eli Lilly	81	$656,943
Sun Pharmaceutical Industries Inc.	399	$630,939
Sanofi US Services Inc.	54	$619,809
Bausch Health US, LLC	28	$581,024
Ortho Dermatologics, A Division Of Bausch Health US, LLC	311	$554,541
Lilly USA, LLC	439	$490,298
Janssen Research & Development, LLC	19	$365,914
UCB, Inc.	341	$358,512
Pfizer	220	$337,828
Novartis	190	$293,469
LEO Pharma Inc.	142	$276,591
Takeda Pharmaceuticals U.S.A., Inc.	50	$265,784
AbbVie	48	$201,202
Dermavant Sciences, Inc.	514	$190,831
Galderma Laboratories, L.p.	93	$182,187
Arcutis Biotherapeutics, Inc.	110	$164,034
Sanofi	44	$143,471
Amgen	46	$140,605
LEO Pharma AS	45	$113,505
Mayne Pharma Commercial LLC	8	$102,471
Regeneron	17	$88,271
EPI Health, LLC	24	$73,060
Mindera Corp	8	$64,560
Taro Pharmaceuticals USA, Inc.	36	$45,015
Organon	23	$33,263
Dermira, Inc.	16	$29,966
Dr.reddy's Laboratories,inc.	5	$29,848
Boehringer Ingelheim	17	$27,863
Bristol Myers Squibb	15	$21,116
Sanofi-aventis U.S. LLC	7	$20,556
Argenx US, Inc.	3	$19,460
Novartis Pharma AG	3	$18,995
VYNE Pharmaceuticals Inc.	10	$17,237
Regeneron Healthcare Solutions, Inc.	8	$13,594
Galderma Research & Development, LLC	2	$8,000
Biofrontera Inc.	7	$7,445
Aclaris Therapeutics, Inc.	7	$6,422
Johnson & Johnson(2 entities)	14	$6,174
Janssen Scientific Affairs, LLC	9	$5,373
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$4,650
Kowa Pharmaceuticals America, Inc.	3	$4,222
Botanix SB Inc	1	$2,200
Orapharma, A Division Of Bausch Health US, LLC	1	$2,000
Boehringer Ingelheim International GmbH	1	$1,905
LNHC, Inc	1	$1,500
Zerigo Health, Inc.	1	$1,000
Strata Skin Sciences, Inc.	1	$700
Glenmark Therapeutics Inc.	3	$307
Bausch & Lomb, A Division Of Bausch Health US, LLC	1	$50
AstraZeneca	1	$37

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Winlevi$295,413
TALTZ$266,174
Bimzelx$255,751
DUOBRII$250,821
ILUMYA$210,899
COSENTYX$202,911
Sotyktu$158,744
ADBRY$150,732
OPZELURA$137,699
CIBINQO$130,705
ABSORICA LD$101,202
VTAMA$89,685
SILIQ$85,170
EBGLYSS$80,679
Klisyri$73,070
ARAZLO$65,041
JUBLIA$63,435
WYNZORA$58,423
Otezla$52,148
ORACEA$49,250

How this compares

$9,983,187 in reported general payments places this provider in the 95th percentile of 128 dermatology providers in Kentucky.

See all dermatology providers in Kentucky →

Medicare billing

Part B allowed, 2024

$122,060

Medicare patients

Services billed

433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Triamcinolone Acetonide	12	$187

Paid to pharmacies, not to this prescriber.

Other dermatology in Lousiville

Cindy OwenLouisville$4.2M
James AllredFranklin$2.7M
Melissa KnucklesCorbin$1.6M
Artis TruettOwensboro$1.4M
James WhartonLexington$1.2M
Jae JungLouisville$651K
James JacksonLouisville$404K
Joseph FowlerLouisville$321K
Tanner ParrentHopkinsville$174K
Cassey VesselsOwensboro$92K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →